UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934 (Amendment No.)

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐ Definitive Proxy Statement

☒ Definitive Additional Materials

☐ Soliciting Material Pursuant to §240.14a-12

Oncternal Therapeutics, Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

☒ No fee required

☐ Fee paid previously with preliminary materials

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

ONCTERNAL therapeutics P.O. BOX 8016, CARY, NC 27512-9903 Your vote matters! Oncternal Therapeutics, Inc. Annual Meeting of Stockholders Thursday, June 20, 2024 7:30 AM, Pacific Time Annual Meeting to be held live via the Internet. Please visit www.proxydocs.com/ONCT for more details. You must register to attend the meeting online and/or participate at www.proxydocs.com/ONCT For a convenient way to view proxy materials, VOTE, and obtain directions to attend the meeting go to www.proxydocs.com/ONCT To vote your proxy while visiting this site, you will need the 12 digit control number in the box below. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting. Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet. If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's meeting, you must make this request on or before June 1 0, 2024. SEE REVERSE FOR FULL AGENDA Important Notice Regarding the Availability of Proxy Materials for the Stockholders Meeting To Be Held On June 20, 2024 For Stockholders of record as of April 22, 2024 To order paper materials, use one of the following methods. Internet: : www.investorelections.com/ONCT Call: : 1-865-643-8133 Email: paper@investorelections.com * If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located below) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material. Have the 12 digit control number located in the box above available when you access the website and follow the instructions. Copyright 0 2024 BetaNXT, Inc. or its affiliates. All Rights Reserved

 

ONCTERNAL Oncternal Therapeutics, Inc. Annual Meeting of Stockholders therapeutics THE BOARD OF DIRECTORS RECOMMENDS A VOTE; FOR ALL DIRECTOR NOMINEES AND FOR PROPOSALS 2 AND 3 PROPOSAL To two directors for a three-year term to expire at the 2027 annual meeting of stockholders; 1.01 Jill DeSimone 102 J Wii's, Phi) Ratification of the appoingment of BOO USA, as our independent registered accountants for the year ending December 31, 2024; To approve, on an basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Comm and To transact such other business as may be properly brought before the meeting or any adjournment or postponement thereof